COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 39 filers reported holding COMPASS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $124,679 | -67.0% | 63,289 | -46.8% | 0.00% | – |
Q2 2023 | $378,089 | -27.8% | 118,896 | -25.7% | 0.00% | – |
Q1 2023 | $523,409 | +61.3% | 160,064 | +148.2% | 0.00% | – |
Q4 2022 | $324,425 | +1522.1% | 64,498 | +627.0% | 0.00% | – |
Q3 2022 | $20,000 | +900.0% | 8,872 | +1347.3% | 0.00% | – |
Q2 2022 | $2,000 | -94.6% | 613 | -97.7% | 0.00% | – |
Q1 2022 | $37,000 | -33.9% | 26,977 | +54.4% | 0.00% | – |
Q4 2021 | $56,000 | – | 17,473 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 914,630 | $2,908,523 | 3.52% |
Foresite Capital Management V, LLC | 1,324,071 | $4,210,546 | 3.08% |
CHI Advisors LLC | 2,829,712 | $8,998,484 | 2.73% |
Monashee Investment Management LLC | 1,969,296 | $6,262,361 | 1.50% |
Orbimed Advisors | 22,362,850 | $71,113,863 | 1.29% |
Prosight Management, LP | 2,167,994 | $6,894,220 | 1.03% |
Vivo Capital, LLC | 3,556,023 | $11,308,153 | 0.78% |
BRAIDWELL LP | 5,954,273 | $18,934,588 | 0.62% |
Rock Springs Capital Management LP | 5,513,788 | $17,533,846 | 0.42% |
CAXTON CORP | 43,466 | $138,220 | 0.40% |